Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice

Diabetologia

Volumn 57, Issue 3, 2014, Pages 603-613

  Kang, Li ^a,b   Mayes, Wesley H ^a   James, Freyja D ^a   Bracy, Deanna P ^a   Wasserman, David H ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Capillary density; Collagen IV; Extracellular matrix; High fat diet

Indexed keywords

COLLAGEN TYPE 5; GELATINASE B; GLUCOSE BLOOD LEVEL; INSULIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL; BODY WEIGHT; EXTRACELLULAR MATRIX; GENE DELETION; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INSULIN RESISTANCE; LIPID DIET; METABOLISM; MOUSE; SECRETION (PROCESS); SKELETAL MUSCLE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; COLLAGEN TYPE V; DIET, HIGH-FAT; EXTRACELLULAR MATRIX; GENE DELETION; GLUCOSE CLAMP TECHNIQUE; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN RESISTANCE; MATRIX METALLOPROTEINASE 9; MICE; MUSCLE, SKELETAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84894575537     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3128-1     Document Type: Article

References (45)

1. Richardson DK, Kashyap S, Bajaj M et al (2005) Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 280:10290-10297
2. Berria R, Wang L, Richardson DK et al (2006) Increased collagen content in insulin-resistant skeletal muscle. Am J Physiol Endocrinol Metab 290:E560-E565
3. Kang L, Ayala JE, Lee-Young RS et al (2011) Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice. Diabetes 60:416-426
4. Kang L, Lantier L, Kennedy A et al (2013) Hyaluronan accumulates with high fat feeding and contributes to insulin resistance. Diabetes 62:1888-1896
5. Thrailkill KM, Clay Bunn R, Fowlkes JL (2009) Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. Endocrine 35:1-10
6. Brinckerhoff CE, Matrisian LM (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3:207-214
7. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 8:352-356
8. Martignetti JA, Aqeel AA, Sewairi WA et al (2001) Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28:261-265
9. Peng WJ, Yan JW, Wan YN et al (2012) Matrix Metalloproteinases: a review of their structure and role in systemic sclerosis. J Clin Immunol 32:1409-1414
10. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135-1149
11. Derosa G, Ferrari I, D'Angelo A et al (2008) Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium J Endothelial Cell Res 15:219-224
12. Signorelli SS, Malaponte G, Libra M et al (2005) Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease. Vasc Med 10:1-6
13. Tinahones FJ, Coin-Araguez L, Mayas MD et al (2012) Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol 12:4
14. Vu TH, Shipley JM, Bergers G et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422
15. Acuff HB, Carter KJ, Fingleton B, Gorden DL, Matrisian LM (2006) Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res 66:259-266
16. Ducharme A, Frantz S, Aikawa M et al (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55-62
17. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681-1689
18. Vermaelen KY, Cataldo D, Tournoy K et al (2003) Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma. J Immunol 171:1016-1022
19. Collins S, Martin TL, Surwit RS, Robidoux J (2004) Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81:243-248
20. Ayala JE, Bracy DP, McGuinness OP, Wasserman DH (2006) Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55:390-397
21. James DE, Burleigh KM, Kraegen EW (1986) In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin. J Biol Chem 261:6366-6374
22. Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH (2007) Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes 56:1025-1033
23. Steele R, Wall JS, de Bodo RC, Altszuler N (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24
24. Kraegen EW, James DE, Jenkins AB, Chisholm DJ (1985) Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353-E362
25. Bonner JS, Lantier L, Hasenour CM, James FD, Bracy DP, Wasserman DH (2013) Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Diabetes 62:572-580
26. Olfert IM, Howlett RA, Tang K et al (2009) Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 587:1755-1767
27. Tschop MH, Speakman JR, Arch JR et al (2012) A guide to analysis of mouse energy metabolism. Nat Methods 9:57-63
28. Kaiyala KJ, Morton GJ, Leroux BG, Ogimoto K, Wisse B, Schwartz MW (2010) Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes 59:1657-1666
29. Kaiyala KJ, Schwartz MW (2011) Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes 60:17-23
30. Hollborn M, Stathopoulos C, Steffen A, Wiedemann P, Kohen L, Bringmann A (2007) Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Investig Ophthalmol Vis Sci 48:4360-4367
31. Bergers G, Brekken R, McMahon G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744
32. Pompei LM, Steiner ML, Theodoro TR et al (2013) Effect of estrogen therapy on vascular perlecan and metalloproteinases 2 and 9 in castrated rats. Climacteric J Int Menopause Soc 16:147-153
33. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1167
34. Lee YS, Li P, Huh JY et al (2011) Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 60:2474-2483
35. Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539-552
36. Amento EP, Ehsani N, Palmer H, Libby P (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11:1223-1230
37. Galis ZS, Muszynski M, Sukhova GK et al (1994) Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75:181-189
38. Tooke JE, Goh KL (1998) Endotheliopathy precedes type 2 diabetes. Diabetes Care 21:2047-2049
39. Tooke J (1999) The association between insulin resistance and endotheliopathy. Diabetes Obes Metab 1(Suppl 1):S17-S22
40. Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS (1997) Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 46(Suppl 2):S9-S13
41. Kubota T, Kubota N, Kumagai H et al (2011) Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab 13:294-307
42. Braet F, Wisse E (2012) AFM imaging of fenestrated liver sinusoidal endothelial cells. Micron 43:1252-1258
43. Cogger VC, McNerney GP, Nyunt T et al (2010) Three-dimensional structured illumination microscopy of liver sinusoidal endothelial cell fenestrations. J Struct Biol 171:382-388
44. Konstantinopoulos PA, Karamouzis MV, Papatsoris AG, Papavassiliou AG (2008) Matrix metalloproteinase inhibitors as anticancer agents. Int J Biochem Cell Biol 40:1156-1168
45. Hu J, van den Steen PE, Sang QX, Opdenakker G (2007) Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov 6:480-498